Found 4 matching trials
Iruplinalkib in ALK-Positive Advanced Lung Adenocarcinoma After Lorlatinib
N/AThis observational study aims to evaluate the real-world effectiveness and ...
Location
Peking University Shenzhen Hospital
An Exploratory Study of Efficacy and Safety of Iruplinalkib Tablets in Patients With ROS1 Positive Non-small Cell Lung Cancer
EARLY_PHASE1This is a single-arm, open, multicenter exploratory clinical trial to obser...
Location
Henan cancer hospital
Iruplinalkib Tablets as Postoperative Adjuvant Therapy in Stage IA ALK-positive NSCLC With High-risk Factors
PHASE2The primary objective is to evaluate the efficacy and safety of Iruplinalki...
Location
Multiple Locations
WX-0593 Combined With Concurrent Chemoradiotherapy in Unresectable Locally Advanced NSCLC
PHASE2The aim of this trial is to evaluate the safety of WX-0593 combined with co...
Location
Shandong Cancer Hospital and Institute